Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_assertion type Assertion NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_head.
- NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_assertion description "[The mean number of metastatic disease sites in patients within the ALK rearranged cohort was significantly greater than that of the triple negative cohort (mean = 3.6 sites vs 2.5 sites, P < .0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_provenance.
- NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_assertion evidence source_evidence_literature NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_provenance.
- NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_assertion SIO_000772 22282022 NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_provenance.
- NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_assertion wasDerivedFrom befree-2016 NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_provenance.
- NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_assertion wasGeneratedBy ECO_0000203 NP956399.RA4BRv_ucvOIgxsDu0g_nPKQvWeZ0ehf2Ei6pnsoBS7sY130_provenance.